National Health Investors (NYSE:NHI) Issues FY24 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $4.43-$4.44 for the period, compared to the consensus EPS estimate of $4.52.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on NHI. Truist Financial increased their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Bank of America assumed coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Finally, Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and upped their target price for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $73.29.

National Health Investors Stock Performance

Shares of NHI traded up $0.81 on Tuesday, reaching $76.73. 340,584 shares of the company’s stock traded hands, compared to its average volume of 190,436. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $3.33 billion, a PE ratio of 26.00, a PEG ratio of 5.09 and a beta of 1.05. The stock’s 50 day simple moving average is $80.53 and its two-hundred day simple moving average is $73.03. National Health Investors has a 52-week low of $49.25 and a 52-week high of $86.13.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm had revenue of $84.97 million during the quarter, compared to analysts’ expectations of $64.95 million. During the same period in the prior year, the business earned $1.06 earnings per share. The business’s quarterly revenue was up 9.1% compared to the same quarter last year. On average, analysts forecast that National Health Investors will post 4.48 earnings per share for the current fiscal year.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.